Results 1 to 10 of about 44,981 (233)

Evaluating the Risk of Coagulopathy in Cephalosporins with Different Side Chains: A Propensity Score–Weighted Study [PDF]

open access: yesMedicina
Background and Objectives: Cephalosporins containing N-hydroxyethyltetrazolethiol (HTT) or N-methylthiotetrazole (NMTT) side chains, such as flomoxef and cefoperazone, have been linked to coagulation abnormalities.
Chien-Hsiang Tai   +2 more
doaj   +2 more sources

Cefazolin-induced coagulopathy: a case report [PDF]

open access: yesJournal of Medical Case Reports
Objective We report a case of cefazolin-induced coagulopathy, highlighting the importance of maintaining a high index of suspicion for this rare adverse effect of cefazolin.
Olivier Zerbib   +4 more
doaj   +2 more sources

Cefazolin inoculum effect among methicillinsusceptible Staphylococcus aureus isolated from patients with skin infections [PDF]

open access: yesКлиническая микробиология и антимикробная химиотерапия, 2021
Objective. To evaluate frequency and intensity of cefazolin inoculum effect among methicillin-susceptible staphylococci isolated from patients with skin infections. Materials and Methods.
Vaganova А.N.   +7 more
doaj   +1 more source

Removal of the Cefazolin Antibiotic Using Polyaniline Resin-Polyethylene Glycol from Aqueous Medium [PDF]

open access: yesآب و فاضلاب, 2022
Cefazolin is a widely used antibiotic in the treatment of bacterial infections that enters the water sources in original or metabolized form through the discharge of sewage and effluents.
Mozhgan Arman   +3 more
doaj   +1 more source

Clinical pharmacology of cefazolin

open access: yesAdvances in Biomedical and Health Sciences, 2022
Cefazolin is a first-generation cephalosporin that is active against gram-positive bacteria and has modest activity against gram-negative organisms, and cefazolin is excreted by glomerular filtration.
Gian Maria Pacifici
doaj   +1 more source

Overproduction of Chromosomal ampC β-Lactamase Gene Maintains Resistance to Cefazolin in Escherichia coli Isolates

open access: yesMicrobiology Spectrum, 2022
Cefazolin, an active in vitro agent against Escherichia coli, is used to treat urinary and biliary tract infections. Cefazolin is used widely as an antibiotic, and the increase in the emergence of cefazolin-resistant E.
Masato Kawamura   +7 more
doaj   +1 more source

Durability of the two-lumen catheter in hemodialysis patients; Ethanol 70%-heparin versus cefazolin-heparin: a randomized, double-blind clinical trial study [PDF]

open access: yesJournal of Nephropharmacology, 2023
Introduction: Maintenance of hemodialysis catheters is essential for the patients and medical staff due to their repeated use for hemodialysis and other therapeutic interventions in the hospital.
Hadi Yousefi   +7 more
doaj   +1 more source

Population pharmacokinetic model of cefazolin in total hip arthroplasty

open access: yesScientific Reports, 2021
Cefazolin is an antibiotic recommended for infection prevention in total hip arthroplasty (THA). However, the dosing regimen necessary to achieve therapeutic concentrations in obese patients remains unclear.
J. Lanoiselée   +9 more
doaj   +1 more source

Safety of Cefazolin in Prophylaxis in Β-Lactam Allergic Children

open access: yesBezmiâlem Science, 2022
Objective:Cefazolin is a first-generation cephalosporin, particularly effective against gram positive agents such as staphylococci and streptococci. Despite this narrow spectrum, it is important in surgical prophylaxis.
Ayşe SÜLEYMAN   +3 more
doaj   +1 more source

Increased Rate of Early Periprosthetic Joint Infection in Total Hip Arthroplasty With the Use of Alternatives to Cefazolin Despite Additional Gram-Negative Coverage

open access: yesArthroplasty Today, 2022
Background: Periprosthetic joint infection (PJI) remains one of the most devastating complications following total joint arthroplasty. Appropriate prophylactic antimicrobial administration and antibiotic stewardship are major factors impacting the risk ...
Dionisio Ortiz, III, MD   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy